Giovanni Cagnotto (@gio_cagnotto) 's Twitter Profile
Giovanni Cagnotto

@gio_cagnotto

Rheumatologist at Skåne University Hospital, Malmö, Sweden

ID: 1750506133519831040

calendar_today25-01-2024 13:09:28

4 Tweet

2 Followers

35 Following

Cochrane Sweden (@cochranesweden) 's Twitter Profile Photo

Many Nordic clinical trials were reported late—or not at all - 1 in 4 trials remained unreported - Only 50% had results 2 years post-completion - Just 2.3% posted summary results in 1 year Urgent action is needed to improve transparency! jclinepi.com/article/S0895-… #ClinicalTrials

Many Nordic clinical trials were reported late—or not at all
- 1 in 4 trials remained unreported
- Only 50% had results 2 years post-completion
- Just 2.3% posted summary results in 1 year

Urgent action is needed to improve transparency!
jclinepi.com/article/S0895-… #ClinicalTrials
Cochrane Sweden (@cochranesweden) 's Twitter Profile Photo

We included 25 RCTs (7857 participants) on TNFi for psoriatic arthritis. In csDMARD-inadequate responders, TNFi probably result in a large clinical improvement, lower disease activity, small decrease in radiographic progression, and better quality of life cochranelibrary.com/cdsr/doi/10.10…

We included 25 RCTs (7857 participants) on TNFi for psoriatic arthritis. In csDMARD-inadequate responders, TNFi probably result in a large clinical improvement, lower disease activity, small decrease in radiographic progression, and better quality of life
cochranelibrary.com/cdsr/doi/10.10…
Giovanni Cagnotto (@gio_cagnotto) 's Twitter Profile Photo

Our latest Cochrane review on the effectiveness and safety of TNFi in psoriatic arthritis is now published! 📊 We analyzed 25 RCTs with 7,857 participants with psoriatic arthritis. cochranelibrary.com/cdsr/doi/10.10… #CochraneReview #PsoriaticArthritis Cochrane Sweden Matteo Bruschettini